Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
TMiRob
company
About
A medical robot developer that works with hospitals and clinics to develop medical robots to improve the work efficiency of medical workers.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ¥40M
- Industries
- Health Care,Robotics,Wellness
- Founded date
- Jan 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
TMiRob is a medical robot developer that works with hospitals and clinics to develop medical robots to improve the work efficiency of medical workers. The medical robots developed by TMiRob can be used in medical treatment assistance and nursing services in hospitals and clinics.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥40M
TMiRob has raised a total of
¥40M
in funding over 2 rounds. Their latest funding was raised on
Mar 26, 2019 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 26, 2019 | Series B | — | 1 | — | — | Detail |
| May 8, 2017 | Series A | ¥40M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
TMiRob is funded by 3 investors.
Cantor Jungle
and Chuangfu Investment Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Cantor Jungle
|
— | Series B |
|
|
— | Series A |
Cash Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
